Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02JPV
|
|||
Drug Name |
N-(benzimidazole/indole) benzoic acid derivative 2
|
|||
Synonyms |
PMID28895472-Compound-18
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
ASTELLAS PHARMA INC. FURUTANI, Takashi ENJO, Kentaro KIKUCHI, AyaAstellas Pharma Inc. KAKEFUDA, Akio KONDOH, Yutaka HIRANO, Masaak
|
|||
Structure |
Download2D MOL |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Dihydrodiol dehydrogenase type I (AKR1C3) | Target Info | Inhibitor | [1] |
Target's Patent Info | Dihydrodiol dehydrogenase type I (AKR1C3) | Target's Patent Info | [1] | |
BioCyc | Superpathway of steroid hormone biosynthesis | |||
Allopregnanolone biosynthesis | ||||
Androgen biosynthesis | ||||
KEGG Pathway | Steroid hormone biosynthesis | |||
Arachidonic acid metabolism | ||||
Metabolic pathways | ||||
Ovarian steroidogenesis | ||||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | |||
Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
Reactome | Retinoid metabolism and transport | |||
WikiPathways | Metapathway biotransformation | |||
Benzo(a)pyrene metabolism | ||||
Arachidonic acid metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review.Expert Opin Ther Pat. 2017 Dec;27(12):1329-1340. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.